Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk

A cohort of 650 patients treated for localized prostate cancer (PCa) with CyberKnife<sup>TM</sup> ultra-hypofractionated radiotherapy between 2011 and 2018 was retrospectively analyzed in terms of survival, patterns of failure, and outcomes of second-line definitive salvage therapies. Th...

Description complète

Détails bibliographiques
Auteurs principaux: Marcin Miszczyk, Monika Szołtysik, Maja Hasterok, Gregor Goldner, Paweł Rajwa, Agnieszka Namysł-Kaletka, Aleksandra Napieralska, Małgorzata Kraszkiewicz, Małgorzata Stąpór-Fudzińska, Bartłomiej Tomasik, Grzegorz Woźniak, Grzegorz Głowacki, Konrad Kaminiów, Matthias Moll, Łukasz Magrowski, Wojciech Majewski
Format: Article
Langue:English
Publié: MDPI AG 2022-09-01
Collection:Biomedicines
Sujets:
prostate cancer
stereotactic body radiotherapy
radiotherapy
hypofractionated
survival
prognosis
Accès en ligne:https://www.mdpi.com/2227-9059/10/10/2446

Internet

https://www.mdpi.com/2227-9059/10/10/2446

Documents similaires